Unpacking OpenAI for International Financial Strategies
Eye on AI
00:00
Accelerating Drug Discovery: OpenAI's Partnership with the FDA
This chapter explores OpenAI's partnership with the U.S. government, focusing on a major data center initiative and collaboration with the FDA. It emphasizes the promising AI tool, CDER GPT, designed to improve drug testing efficiency while navigating the complexities of the drug evaluation process.
Transcript
Play full episode
